Priority Date: 05.01.12 (US 201261583388P)

LIPOSOMALLY ENCAPSULATED REDUCED GLUTATHIONE FOR MANAGEMENT OF CANCER, INCLUDING WITH OTHER PHARMACEUTICAL COMPOSITIONS

  • Application ID: EP13733563
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 51 - 200 employees
Company dna isarpatent
operating since 1951
Headquarter in Munich and 2 offices
active in Legal Services, IP Consulting, and IP-related Communication Service

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 190 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 05.01.2012 - Priority Date (US 201261583388P)
  • 11.07.2013 - Publication A2 (WO2013103924)
  • 27.05.2015 - Publication A2 (EP2874640)